A panel of experts in the management of myeloproliferative neoplasms provides a lively discussion on current and emerging treatment options for patients with primary myelofibrosis or polycythemia vera.
OncLive Peer Exchange®
Graft-vs-Host Disease (GVHD) is a challenging complication of allogeneic transplantation. In this peer exchange, leaders in the field will share their thoughts on the biology and presentation of GVHD, the diagnosis and staging of GVHD, initial management of GVHD, and steroid-refractory GVHD.
Thought leaders in thoracic oncology, Neal Navani, MRCP, MSc, PhD, Gary Doherty, MRCP, PhD, Christian Grohé, MD, and Solange Peters, MD, PhD, provide a lively discussion on the impact of molecular testing on treatment algorithms in EGFR-mutant non-small cell lung cancer and share key insights into emerging research on adjuvant treatment options.
Experts review current treatment options and emerging strategies for advanced endometrial cancer, including data from the Society of Gynecologic Oncology 2021 Virtual Annual Meeting.
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
3
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
4
The OncFive: Top Oncology Articles for the Week of 5/31
5